Terms: = Pancreatic cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
2456 results:
1. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
2. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
3. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
4. treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer.
Zhang LT; Zhang Y; Cao BY; Wu CC; Wang J
World J Gastroenterol; 2024 Mar; 30(12):1739-1750. PubMed ID: 38617739
[TBL] [Abstract] [Full Text] [Related]
5. Short- and long-term outcomes after distal pancreatectomy with radiologic infiltration of splenic vessels for pancreatic ductal adenocarcinoma.
Blanco-Fernández G; Serradilla-Martín M; Rotellar F; Latorre R; Jaén-Torrejimeno I; Muñoz-Forner E; Villodre C; Carabias-Hernández A; Kälviäinen-Mejía HK; Gordillo SE; de la Plaza R; Armas-Conde N; Garcés-Albir M; Morote SC; Manuel-Vázquez A; Serrablo A; Pardo F; Sabater L; Muñoz MPS; Ramia JM
J Gastrointest Surg; 2024 Apr; 28(4):467-473. PubMed ID: 38583897
[TBL] [Abstract] [Full Text] [Related]
6. Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
Wu Z; Zhang Q; Jin Y; Zhang X; Chen Y; Yang C; Tang X; Jiang H; Wang X; Zhou X; Yu F; Wang B; Guan M
BMC Cancer; 2024 Apr; 24(1):411. PubMed ID: 38566028
[TBL] [Abstract] [Full Text] [Related]
7. A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Shi JM; Li N; Jiang LM; Yang L; Wang SL; Song YW; Liu YP; Fang H; Lu NN; Qi SN; Chen B; Li YX; Zhao DB; Tang Y; Jin J
Sci Rep; 2024 Mar; 14(1):7522. PubMed ID: 38553594
[TBL] [Abstract] [Full Text] [Related]
8. LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.
Musher BL; Rowinsky EK; Smaglo BG; Abidi W; Othman M; Patel K; Jawaid S; Jing J; Brisco A; Leen AM; Wu M; Sandin LC; Wenthe J; Eriksson E; Ullenhag GJ; Grilley B; Leja-Jarblad J; Hilsenbeck SG; Brenner MK; Loskog ASI
Lancet Oncol; 2024 Apr; 25(4):488-500. PubMed ID: 38547893
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With pancreatic cancer Treated With Perioperative Adjuvant Chemotherapy.
Kawahara S; Aoyama T; Murakawa M; Kanemoto R; Takahashi D; Kamioka Y; Hashimoto I; Maezawa Y; Kobayashi S; Ueno M; Yamamoto N; Oshima T; Yukawa N; Rino Y; Saito A; Morinaga S
Anticancer Res; 2024 Apr; 44(4):1711-1718. PubMed ID: 38537971
[TBL] [Abstract] [Full Text] [Related]
10. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer.
Brown NF; Murray ER; Cutmore LC; Howard P; Masterson L; Zammarchi F; Hartley JA; van Berkel PH; Marshall JF
Pancreatology; 2024 May; 24(3):445-455. PubMed ID: 38519394
[TBL] [Abstract] [Full Text] [Related]
11. [Effectiveness of minimally invasive surgery in the treatment of pancreatic acinar cell carcinoma].
Tao M; Yuan CH; Ma CL; Jiang B; Li L; Wang HY; Xiu DR
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):950-955. PubMed ID: 38514344
[No Abstract] [Full Text] [Related]
12. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial.
Timmer FEF; Geboers B; Ruarus AH; Vroomen LGPH; Schouten EAC; van der Lei S; Vos DJW; Dijkstra M; Schulz HH; Bakker J; van den Bemd BAT; van den Tol PM; Puijk RS; Lissenberg-Witte BI; de Gruijl TD; de Vries JJJ; Lagerwaard FJ; Scheffer HJ; Bruynzeel AME; Meijerink MR
Lancet Gastroenterol Hepatol; 2024 May; 9(5):448-459. PubMed ID: 38513683
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal adenocarcinoma.
Knipper K; Hussein Y; Simon AG; Fretter C; Damanakis AI; Zhao Y; Bruns CJ; Schmidt T; Popp FC; Quaas A; Lyu SI;
J Cancer Res Clin Oncol; 2024 Mar; 150(3):137. PubMed ID: 38502354
[TBL] [Abstract] [Full Text] [Related]
14. Prediction of disease recurrence in patients after complete pancreatic NET (PanNET) G2 resection.
Olearska H; Sowa-Staszczak A; Morawiec-Sławek K; Kurzyńska A; Kolasa M; Tkacz E; Szumińska M; Hubalewska-Dydejczyk A; Opalinska M
Endokrynol Pol; 2024; 75(1):102-108. PubMed ID: 38497396
[TBL] [Abstract] [Full Text] [Related]
15. Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial.
Jiang Z; Xie Y; Zhang W; Du C; Zhong Y; Zhu Y; Jiang L; Dou L; Shao K; Sun Y; Xue Q; Tian Y; Gao S; Zhao D; Zhou A
Gastric Cancer; 2024 May; 27(3):571-579. PubMed ID: 38457083
[TBL] [Abstract] [Full Text] [Related]
16. Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic pancreatic Surgery (TAPS) Consortium study.
Theijse RT; Stoop TF; Janssen QP; Prakash LR; Katz MHG; Doppenberg D; Tzeng CD; Wei AC; Zureikat AH; Groot Koerkamp B; Besselink MG
Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38456678
[TBL] [Abstract] [Full Text] [Related]
17. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
[TBL] [Abstract] [Full Text] [Related]
18. A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.
Enzler T; Nguyen A; Misleh J; Cline VJ; Johns M; Shumway N; Paulson S; Siegel R; Larson T; Messersmith W; Richards D; Chaves J; Pierce E; Zalupski M; Sahai V; Orr D; Ruste SA; Haun A; Kawabe T
Eur J Cancer; 2024 Apr; 201():113950. PubMed ID: 38422585
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan.
Yamashita K; Oka S; Yamada T; Mitsui K; Yamamoto H; Takahashi K; Shiomi A; Hotta K; Takeuchi Y; Kuwai T; Ishida F; Kudo SE; Saito S; Ueno M; Sunami E; Yamano T; Itabashi M; Ohtsuka K; Kinugasa Y; Matsumoto T; Sugai T; Uraoka T; Kurahara K; Yamaguchi S; Kato T; Okajima M; Kashida H; Akagi Y; Ikematsu H; Ito M; Esaki M; Kawai M; Yao T; Hamada M; Horimatsu T; Koda K; Fukai Y; Komori K; Saitoh Y; Kanemitsu Y; Takamaru H; Yamada K; Nozawa H; Takayama T; Togashi K; Shinto E; Torisu T; Toyoshima A; Ohmiya N; Kato T; Otsuji E; Nagata S; Hashiguchi Y; Sugihara K; Ajioka Y; Tanaka S
J Gastroenterol; 2024 May; 59(5):376-388. PubMed ID: 38411920
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of outcomes following surgical resection, percutaneous ablation or stereotactic body radiation therapy in early-stage, solitary and small (≤3 cm) treatment-naïve hepatocellular carcinoma.
Maher AM; Shanker M; Liu HYH; Lee Y; Leggett D; Hodgkinson P; Pryor D; Stuart KA
Cancer Med; 2024 Feb; 13(3):e6978. PubMed ID: 38400681
[TBL] [Abstract] [Full Text] [Related]
[Next]
